Significant role for p16INK4a in p53-independent telomere-directed senescence

Current Biology

Volumn 14, Issue 24, 2004, Pages 2302-2308

  Jacobs, Jacqueline J L ^a   De Lange, Titia ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; PROTEIN P16INK4A; PROTEIN P53; TELOMERIC REPEAT BINDING FACTOR 2;

ARTICLE; CELL AGING; CELL CULTURE; COMPARATIVE STUDY; DNA DAMAGE; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; TELOMERE;

BROMODEOXYURIDINE; CELL AGING; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA DAMAGE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 11144268164     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2004.12.025     Document Type: Article

References (44)

1. Kiyono T., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., Klingelhutz A.J. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:1998;84-88
2. Dickson M.A., Hahn W.C., Ino Y., Ronfard V., Wu J.Y., Weinberg R.A., Louis D.N., Li F.P., Rheinwald J.G. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20:2000;1436-1447
3. Munro J., Steeghs K., Morrison V., Ireland H., Parkinson E.K. Human fibroblast replicative senescence can occur in the absence of extensive cell division and short telomeres. Oncogene. 20:2001;3541-3552
4. Ramirez R.D., Morales C.P., Herbert B.S., Rohde J.M., Passons C., Shay J.W., Wright W.E. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15:2001;398-403
5. Morris M., Hepburn P., Wynford-Thomas D. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function. Oncogene. 21:2002;4277-4288
6. Itahana K., Zou Y., Itahana Y., Martinez J.L., Beausejour C., Jacobs J.J., Van Lohuizen M., Band V., Campisi J., Dimri G.P. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol. Cell. Biol. 23:2003;389-401
7. Wei W., Herbig U., Wei S., Dutriaux A., Sedivy J.M. Loss of retinoblastoma but not p16 function allows bypass of replicative senescence in human fibroblasts. EMBO Rep. 4:2003;1061-1066
8. Bond J., Jones C., Haughton M., DeMicco C., Kipling D., Wynford-Thomas D. Direct evidence from siRNA-directed "knock down" that p16(INK4a) is required for human fibroblast senescence and for limiting ras-induced epithelial cell proliferation. Exp. Cell Res. 292:2004;151-156
9. Herbig U., Jobling W.A., Chen B.P., Chen D.J., Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell. 14:2004;501-513
10. Brookes S., Rowe J., Gutierrez Del Arroyo A., Bond J., Peters G. Contribution of p16(INK4a) to replicative senescence of human fibroblasts. Exp. Cell Res. 298:2004;549-559
11. Hara E., Smith R., Parry D., Tahara H., Stone S., Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16:1996;859-867
12. Alcorta D.A., Xiong Y., Phelps D., Hannon G., Beach D., Barrett J.C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA. 93:1996;13742-13747
13. Palmero I., McConnell B., Parry D., Brookes S., Hara E., Bates S., Jat P., Peters G. Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene. 15:1997;495-503
14. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352
15. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602
16. Robles S.J., Adami G.R. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene. 16:1998;1113-1123
17. Shapiro G.I., Edwards C.D., Ewen M.E., Rollins B.J. p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol. Cell. Biol. 18:1998;378-387
18. Piepkorn M. The expression of p16(INK4a), the product of a tumor suppressor gene for melanoma, is upregulated in human melanocytes by UVB irradiation. J. Am. Acad. Dermatol. 42:2000;741-745
19. te Poele R.H., Okorokov A.L., Jardine L., Cummings J., Joel S.P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62:2002;1876-1883
20. de Lange T. Protection of mammalian telomeres. Oncogene. 21:2002;532-540
21. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 92:1998;401-413
22. Smogorzewska A., Karlseder J., Holtgreve-Grez H., Jauch A., de Lange T. DNA Ligase IV-Dependent NHEJ of Deprotected Mammalian Telomeres in G1 and G2. Curr. Biol. 12:2002;1635-1644
23. Takai H., Smogorzewska A., de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13:2003;1549-1556
24. Zhu X.D., Niedernhofer L., Kuster B., Mann M., Hoeijmakers J.H., de Lange T. ERCC1/XPF Removes the 3′ Overhang from Uncapped Telomeres and Represses Formation of Telomeric DNA-Containing Double Minute Chromosomes. Mol. Cell. 12:2003;1489-1498
25. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 426:2003;194-198
26. Stewart S.A., Ben-Porath I., Carey V.J., O'Connor B.F., Hahn W.C., Weinberg R.A. Erosion of the telomeric single-strand overhang at replicative senescence. Nat. Genet. 33:2003;492-496
27. Smogorzewska A., de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21:2002;4338-4348
28. Brookes S., Rowe J., Ruas M., Llanos S., Clark P.A., Lomax M., James M.C., Vatcheva R., Bates S., Vousden K.H., et al. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J. 21:2002;2936-2945
29. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9363-9367
30. Jacobs J.J., Kieboom K., Marino S., DePinho R.A., van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 397:1999;164-168
31. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11:2001;S27-S31
32. Maser R.S., DePinho R.A. Connecting chromosomes, crisis, and cancer. Science. 297:2002;565-569
33. Sharpless N.E., DePinho R.A. Telomeres, stem cells, senescence, and cancer. J. Clin. Invest. 113:2004;160-168
34. Itahana K., Campisi J., Dimri G.P. Mechanisms of cellular senescence in human and mouse cells. Biogerontology. 5:2004;1-10
35. de Lange T. Telomere dynamics and genome instability in human cancer. Greider E.H.B.a.C.W. Telomeres. 1995;265-293 CSH press, CSH
36. Chin K., De Solorzano C.O., Knowles D., Jones A., Chou W., Rodriguez E.G., Kuo W.L., Ljung B.M., Chew K., Myambo K., et al. In situ analyses of genome instability in breast cancer. Nat. Genet. 36:2004;984-988
37. Beausejour C.M., Krtolica A., Galimi F., Narita M., Lowe S.W., Yaswen P., Campisi J. Reversal of human cellular senescence. roles of the p53 and p16 pathways EMBO J. 22:2003;4212-4222
38. Bakkenist C.J., Drissi R., Wu J., Kastan M.B., Dome J.S. Disappearance of the telomere dysfunction-induced stress response in fully senescent cells. Cancer Res. 64:2004;3748-3752
39. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 283:1999;1321-1325
40. Sherr C.J., Roberts J.M. CDK inhibitors. positive and negative regulators of G1-phase progression Genes Dev. 13:1999;1501-1512
41. Brown J.P., Wei W., Sedivy J.M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science. 277:1997;831-834
42. Mitra J., Dai C.Y., Somasundaram K., El-Deiry W.S., Satyamoorthy K., Herlyn M., Enders G.H. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a). Mol. Cell. Biol. 19:1999;3916-3928
43. McConnell B.B., Gregory F.J., Stott F.J., Hara E., Peters G. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2- associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol. Cell. Biol. 19:1999;1981-1989
44. Parry D., Mahony D., Wills K., Lees E. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol. Cell. Biol. 19:1999;1775-1783